AlphAIAlphAI — Financial news for AI agents
marketscreener.comOCT 21 min read$NKE

Morgan Stanley Adjusts Price Target on Nike to $27 From $31, Keeps Underweight Rating

Morgan Stanley lowered its price target for Nike to $27 from $31, maintaining an underweight rating. The stock is currently trading at $35.15, down 0.71% pre-market. The adjustment reflects the firm's valuation and earnings revisions outlook for the company.

Original reporting
marketscreener.com
Published Oct 2, 2026, 10:55 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 11:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$NKE
Bearish
high confidence
Mentioned
$NKE
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$NKEBearishHigh
01

Why it matters

The downgrade could trigger short covering and a modest decline in Nike's share price ahead of the market open.

02

Market read

Analyst target cuts on large-cap stocks often lead to immediate price adjustments, making this a notable short-term trading signal.

03

What to watch

Potential upside from upcoming product launches or international market recovery could offset the downgrade.

Relevance 7/10Novelty 7/10Timing: pre-market today

Background

Morgan Stanley's research team adjusted its valuation assumptions for Nike, reflecting concerns over sales momentum.

Company-level read

Ticker impact

$NKEBearishHigh confidence
Context

Morgan Stanley lowered Nike's price target to $27 from $31 and kept an underweight rating.

Expected impact

downward pressure as investors price in the lower target

Evidence & confidence

Analyst downgrade with a concrete new target is a fresh catalyst for short-term price moves.

Market effects

Sector

May weigh on broader apparel and consumer discretionary stocks as analysts reassess demand outlook.

Regional

Primarily U.S. market impact; limited effect on overseas markets.

Global

Limited to investors tracking large-cap consumer names.

Counterpoint

What could challenge this read

Some investors may view the cut as an overreaction if Nike's recent sales remain strong.

Key entities

  • Research Firm
    Morgan Stanley

    Equity research analyst firm issuing the price target change.

  • Company
    Nike

    Global athletic apparel and footwear manufacturer.

Read at source← All news

Related articles

OCT 2
$NKEMed

Nike's struggles test investor confidence in CEO Hill's turnaround effort

Nike's CEO Elliott Hill faces investor skepticism as the company's market value and earnings have halved since his return. Nike announced job cuts and forecast steeper sales and profit declines for fiscal 2028, with savings expected in fiscal 2029-2030. Challenges include weak performance in China, sportswear, and the Jordan brand, which together account for over half of total sales. Shares dropped 10% in premarket trading on Friday, reaching a 12-year low.

marketscreener.com2 min
OCT 2
$NKEMed

Guggenheim cuts Nike stock price target to $50 on guidance concerns

Guggenheim cut Nike's (NKE) price target to $50 from $60, citing weak guidance despite EPS beats. Revenue missed estimates due to China weakness. NKE shares fell 9%, trading near 52-week lows. Analysts revised earnings down, but some see undervaluation. Management's guidance was below consensus. Other analysts also lowered targets, citing revenue and earnings pressures, especially in China.

investing.com2 min
OCT 2
$NKEHighAI 9/10

Nike Stock Tumbles After Weak Fiscal 2027 Outlook

Nike (NKE) shares dropped 10% after lowering fiscal 2027 outlook due to weak China demand. Q1 revenue fell 4% to $11.2B, net income declined 2% to $712M. Greater China revenue dropped 22%. Nike expects fiscal 2027 revenue to decline by a high-single-digit percentage, with adjusted EPS projected at $1.15-$1.35.

gurufocus.com2 min
OCT 2
$NKEHighAI 9/10

Premarket movers: ike tumbles 10%, Synaptics jumps on $5.7B deal

Nike (NKE) fell 9.6% premarket after mixed Q1 results and weak FY guidance. Synaptics (SYNA) rose 13.8% following a revised $5.7B all-cash acquisition deal by onsemi (ON). Moderna (MRNA) gained 2.2% on Nasdaq-100 inclusion. Fair Isaac (FICO) dropped 6.9% on FHFA mortgage data report. MicroStrategy (MSTR) rose 2.7% after Citi raised its price target.

investing.com2 min